Urolog. pro Praxi, 2007; 8(5): 218-221
New recommendations for hormonal therapy of prostate cancer in combination with radiotherapy
- Urologické oddělení, Fakultní Thomayerova nemocnice Praha
The NCCN (National Comprehensive Cancer Network) practice guidelines in oncology, in its 2nd version in 2007, slightly changed its recommendations for the treatment of prostate cancer. Some of these changes, which concerns combination external beam radiotherapy and androgen deprivation therapy in prostate cancer, are making both guidelines, European and American ones, almost identical. According to these guidelines, external beam radiotherapy in combination with androgen deprivation therapy in patients with T2c-T4 N0/1 M0 can reduce risk of biochemical and clinical progression. Further more, this combination therapy can improve overall survival in selected patients.
Keywords: prostate cancer, androgen deprivation therapy, external beam radiotherapy
Published: October 23, 2007 Show citation
References
- Bolla M, Descotes J, Artignan X, Fourneret P. Adjuvant treatment to radiation: combined hormone therapy and exteranl radiotherapy for locally advanced prostate cancor. BJU Int 2007; 100 (suppl 2): 44-47.
Go to original source... 
Go to PubMed... - Bosserman L, Fizazi K, Lipton A, et al. Randomized trial of denosmus versus Zoledronic acid in prostate cancer patients with bone metastases. Program and abstracts of the American Urological Association 2007 Annual Meeting; May 19-24, 2007; Anaheim, California. Abstract 1016. Go to original source...
- Gallina A, Karakiewicz PI, Walz J, et al. Increased risk of newly diagnosed comorbidities in prostate cancer patients treated with androgen deprivation therapy. Program and abstracts of the American Urological Association 2007 Annual Meeting; May 19-24, 2007; Anaheim, California. Abstract 598. Go to original source...
- Joon DL, Hasegawa M, Sikes C et al. Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiation. Int J Radiat Oncol Biol Phys 1997; 38: 1071-1077. Go to original source... Go to PubMed...
- Malcolm JB, DiBiasio CJ, Womack JH, et al. Association of cerebrovascular accident and myocardial infarction in androgen deprivation therapy. Program and abstracts of the American Urological Association 2007 Annual Meeting; May 19-24, 2007; Anaheim, California. Abstract 597. Go to original source...
- Overgaard M, Jensen MB, Overgaard J et al. Postoperative radiotherapy in high-risk postmenopausal brest-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randimised trial. Lancet 1999; 353: 1641-1648. Go to original source... Go to PubMed...
- Wadhwa VK, Weston R, Parr NJ, Wirral U. Frequency of zolendronic acid to prevent further bone loss in osteoporotic patients requiring androgen deprivation therapy for prostate cancer. Program and abstracts of the American Urological Association 2007 Annual Meeting; May 19-24, 2007; Anaheim, California. Abstract 1017. Go to original source...
- Warde P, Whittington R, Vijayakumar S, Lillis-Hearne P, Mason M. Phase III randomised trial comparing total androgene blokade versus total androgen blokade plus pelvic irradiation in clinical stage T3-4, No, Mo adenocarcinoma of the prostate trial NCT00002633. National Cancer Institute, US National Institute of Health 1995.
- Zitman AL, Prince EA, Nakfoor BM, Park JJ. Androgen deprivation and radiation therapy: sequencing studies using the Shionogi in vivo tumor system. Int J Radiat Oncol Biol Phys 1997; 38: 1067-1070. Go to original source... Go to PubMed...